Meet the team

Zach malchano
Zach Malchano


Brent vaughan
Brent Vaughan

Chief Executive Officer

Tom megerian
Tom Megerian

Chief Medical Officer

Mihaly hajos
Mihály Hajós

Chief Scientific Officer

Everett crossland
Everett Crosland

Chief Commercial Officer

Divya cohen
Divya Cohen

Vice President, Product

Martin williamson
Martin Williams

Vice President, Business Development

Sean gregory
Sean Gregory

Vice President, Health Economics & Market Access

Jennifer newberger
Jennifer Newberger

Vice President, Regulatory & Compliance

Kim kwan
Kim Kwan

Vice President, Research & Development

Kimberly ha
Kimberly Ha

Vice President, PR & Investor Relations

The Founders

Ed boyden
Ed Boyden


Li huei tsai
Li-Huei Tsai


Our Advisory Board has decades of experience

Allan Levey, MD, PhD
Lead Clinical Advisor, Emory University
Director, Emory Brain Health Center, Emory Alzheimer's Disease Research Center; Director, Emory Brain Health Personalized Medicine Institute
Suzanne Craft, PhD
Clinical Advisor, Potential Investigator, Wake Forest University
Professor, Gerontology, Geriatric Medicine, Internal Medicine, Wake Forest University; Director, Wake Forest Alzheimer's Disease Research Center
Douglas Galasko, MD
Clinical Advisor, UC San Diego
Associate Director, Shiley-Marcos ADRC Clinical Core; Professor in Residence, Neurosciences
Paul Solomon, PhD
Investigator, Clinical Advisor, Boston Center for Memory
Founder, Clinical Director, Boston Center for Memory; Investigator, Boston University Alzheimer's Disease Center, Boston, University School of Medicine
Li-Huei Tsai, PhD
Founder, Advisor, MIT
Picower Professor of Neuroscience; Director, The Picower Institute for Learning and Memory; Co-Director, Alana Down Syndrome Center; Professor, Department of Brain aand Cognitive Sciences; Senior Associate Member, Broad Institute
Ed Boyden, PhD
Founder, Advisor, MIT
Y. Eva Tan Professor, Neurotechnology, Howard Hughes Medical Institute, McGovern Institute; Professor, Departments of Brain and Cognitive Sciences, Media Arts and Sciences, and Biological Engineering; Leader, Synthetic Neurobiology Group

Recognized and proud

Latest news and updates

Stay up to date

article placeholder
Ushering in a New Class of Disease-Modifying DTx
Healio media
Cognito Therapeutics, Aetion to partner on AI model that identifies AD patients
Fierce 15
Fierce Medtech's 2021 Fierce 15
article placeholder
Cognito Therapeutics and Providence Health Plan Launch Phase 3 Study to Evaluate Disease-Modifying Therapeutic in Mild Cognitive Impairment